Radical_prostatectomy_for_stage_A_adenocarcinoma_of_the_prostate:_staging_errors_and_their_implications_for_treatment_recommendations_and_disease_outcome._Of_148_patients_with_clinical_stage_A1_(32)_or_A2_(116)_disease_who_had_radical_prostatectomy_only_63%_and_62%,_respectively,_had_pathological_stage_A_disease._Although_25%_of_those_with_clinical_stage_A1_and_9%_of_those_with_clinical_stage_A2_disease_had_no_cancer_at_radical_prostatectomy,_12%_and_29%,_respectively,_had_pathological_stage_C_disease_or_higher._Clinical_Mayo_grade_1_was_never_associated_with_extracapsular_disease_but_60%_of_those_with_grade_3_or_higher_tumor_did_have_extracapsular_disease._Over-all_survival_was_comparable_to_the_expected_survival._Clinical_stage_A2_cancer_was_associated_with_a_significantly_higher_progression_rate_(when_prostate_specific_antigen_values_were_considered,_p_=_0.0011)_and_cancer_death_rate_(p_less_than_0.045)_than_stage_A1_disease,_whereas_pathological_stage_was_not_significantly_related_to_disease_outcome,_possibly_because_of_the_use_of_adjuvant_treatment_(hormonal_or_radiation)_for_some_patients_with_pathological_stage_C_or_higher_disease._The_vagaries_of_clinical_staging_associated_with_stage_A_disease,_as_well_as_the_previously_documented_progression_on_long-term_followup_(8_to_10_years)_in_younger_(60_years_old_or_less)_patients_with_stage_A1_prostate_cancer_make_radical_prostatectomy_with_its_limited_morbidity_an_acceptable_treatment_choice.